Ohio's Weed Enthusiasts Help This Cannabis Company's Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 21 2024
0mins
Source: Benzinga
Financial Performance: Vext Science, Inc. reported a revenue increase to approximately $9 million for Q3 2024, alongside a rise in gross profit to $3.9 million, despite a net loss of $2.5 million and rising operating expenses.
Growth Outlook: The company plans to expand its presence in Ohio by opening more dispensaries by 2025–2026, with analysts projecting significant growth potential for Vext's EBITDA in the state's emerging recreational cannabis market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
